Document is current
Any future updates will be listed below
-
Authors
King, Kyle
Kichuk, Stephen A.
Pittenger, Christopher
Zaboski, Brian A.
- License Information
-
More Information
Article History
Received: 9 May 2025
Accepted: 2 September 2025
First Online: 30 October 2025
Declarations
:
: KK: No conflicts to report. SK: No conflicts to report. BZ: For the past three years, BZ has consulted with Biohaven Pharmaceuticals and received royalties from Oxford University Press. CP: Over the past three years, CP has consulted for companies including Biohaven, Ceruvia, UCB, Freedom Biosciences, Transcend, Alco, Lucid/Care, Nobilis, and Mind Therapeutics, as well as investment firms F-Prime Capital and Madison Avenue Partners. He holds equity in Alco Therapeutics, Mind Therapeutics, and Lucid/Care, and has received research support from Biohaven, Freedom Biosciences, and Transcend Therapeutics. CP receives royalties from Oxford University Press and UpToDate and has filed patents for treatments of OCD and related disorders.
